Oral Aripiprazole Is an Effective Maintenance Treatment in Adolescents with Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial

被引：0
|
作者：
Correll, Christoph U. [1 ]
Kohegyi, Eva [1 ]
Zhao, Cathy [1 ]
Baker, Ross A. [1 ]
McQuade, Robert [1 ]
Salzman, Phyllis [1 ]
Sanchez, Raymond [1 ]
Nyilas, Margaretta [1 ]
Carson, William [1 ]
机构：
[1] Hofstra North Shore LIJ Sch Med, Zucker Hillside Hosp, Glen Oaks, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2014年 / 39卷
关键词：
aripiprazole; maintenance treatment; pediatric; schizophrenia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T90
引用
收藏
页码：S349 / S350
页数：2
相关论文
共 50 条
  • [31] Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial
    Oliver Freudenreich
    Lawrence Herz
    Thilo Deckersbach
    A. Eden Evins
    David C. Henderson
    Corinne Cather
    Donald C. Goff
    Psychopharmacology, 2005, 181 : 358 - 363
  • [32] Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Ochoa, Susana
    Cobo, Jesus
    Miquel, Eva
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Usall, Judith
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (02) : 223 - 231
  • [33] Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar I Disorder: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
    Kemp, David E.
    Calabrese, Joseph R.
    Tran, Quynh-Van
    Pikalov, Andrei
    Eudicone, James M.
    Baker, Ross A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (09) : 1138 - 1144
  • [34] A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia
    McEvoy, Joseph P.
    Daniel, David G.
    Carson, William H., Jr.
    McQuade, Robert D.
    Marcus, Ronald N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2007, 41 (11) : 895 - 905
  • [35] A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression
    Brown, E. Sherwood
    Park, John
    Marx, Christine E.
    Hynan, Linda S.
    Gardner, Claire
    Davila, Domingo
    Nakamura, Alyson
    Sunderajan, Prabha
    Lo, Alexander
    Holmes, Traci
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (12) : 2867 - 2873
  • [36] Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
    Abebaw Fekadu
    Miraf Mesfin
    Girmay Medhin
    Atalay Alem
    Solomon Teferra
    Tsehaysina Gebre-Eyesus
    Teshale Seboxa
    Abraham Assefa
    Jemal Hussein
    Martha T Lemma
    Christina Borba
    David C Henderson
    Charlotte Hanlon
    Teshome Shibre
    Trials, 14
  • [37] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
    Afshar, H.
    Roohafza, H.
    Mousavi, G.
    Golchin, S.
    Toghianifar, N.
    Sadeghi, M.
    Talaei, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
  • [38] Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
    Mueller, Norbert
    Krause, Daniela
    Dehning, Sandra
    Musil, Richard
    Schennach-Wolff, Rebecca
    Obermeier, Michael
    Moeller, Hans-Juergen
    Klauss, Volker
    Schwarz, Markus J.
    Riedel, Michael
    SCHIZOPHRENIA RESEARCH, 2010, 121 (1-3) : 118 - 124
  • [39] Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
    Shim, Joo-Cheol
    Jung, Do-Un
    Jung, Sung-Soo
    Seo, Young-Soo
    Cho, Deuk-Man
    Lee, Ji-Heon
    Lee, Sae-Woom
    Kong, Bo-Geum
    Kang, Je-Wook
    Oh, Min-Kyung
    Kim, Sang-Duk
    McMahon, Robert P.
    Kelly, Deanna L.
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (03) : 660 - 668
  • [40] Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial
    Durgam, Suresh
    Earley, Willie
    Li, Rui
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Fleischhacker, W. Wolfgang
    Nasrallah, Henry A.
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 264 - 271
12345